Pharmaceutical professionals expect digital solutions to solve drug development headaches, with AI already proving disruptive ...

Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ hunt to create drug ...

KAIST researchers have developed a groundbreaking single-atom editing technology using light-powered "molecular scissors" to ...

Over 3,000 drugs have been developed or repurposed using AI. Digital transformation, particularly through AI, is anticipated ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which ...

A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 ...

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

Real-World Data and Real-World Evidence (RWD/RWE) have been utilized not only for drug safety assessment but also for efficacy evaluation for drug approval at global basis. Over the years, many real ...

Writing the documentation that must go alongside the development of new drugs is a highly labor-intensive process: not much ...

Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start. This complexity arises from rigorous study ...

Drug development is the synthesis of large, heterogeneous datasets spanning multiple formats, including text-based, graphical ...